Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EMR | Common Stock | Award | +4.31K | +22.75% | 23.3K | Nov 4, 2024 | Direct | F1, F2 | ||
transaction | EMR | Common Stock | Tax liability | -$104K | -950 | -4.08% | $109.11 | 22.3K | Nov 4, 2024 | Direct | F3, F4 |
transaction | EMR | Common Stock | Award | +3.69K | +16.51% | 26K | Nov 4, 2024 | Direct | F5, F6 |
Id | Content |
---|---|
F1 | Acquisition of shares pursuant to Rule 16b-3 upon payout of 4,314 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2024. |
F2 | Price is not applicable to the acquisition described in Note 1. |
F3 | Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1. |
F4 | Fair market value on date of withholding described in Note 1. |
F5 | Grant to Reporting Person of 3,686 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
F6 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |